Z Squared Inc.
ZSQR · Finance Services · 51.4M shares · -44%/yr ↓ buyback · EDGAR filings ↗
Net buyback after stock comp: -$230K (gross $247K, SBC $478K)
Grade
F38Z Squared — distressed micro firm with deep losses.
Strengths
- Strong current ratio (4.2) but minimal scale
Risks
- Operating margin -957%; ROE -88% (21st pct)
- Going-concern risk; sub-scale
Notable findings
- Going concernand · There is a substantial doubt about our ability to continue as a going concern
- Exec changeRecent 8-K item 5.02 8-K ↗
- Net lossNet loss (net margin -874.3%)
- Buying back stockNet buyback — share count -44%/yr over 3y
- Revenue declineRevenue -86.8% YoY
Quarterly revenue
Last 4 quarters · from SEC filings.
Key metrics
Gross margin
86.7%
Operating margin
-956.9%
Net margin
-874.3%
Return on equity
-87.9%
Return on assets
-73.8%
ROIC
-75.1%
Revenue growth (QoQ)
-86.8%
Debt / equity
0.0×
Current ratio
4.2×
EBITDA
-$12M
Tangible book value
$13M
Insider transactions · last 18 months
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-04-30 | BSG Series CM, LLC | Other | 41.5M | — |
| 2026-04-27 | Burke Michelle Ellen | Grant | 16K | — |
| 2026-02-11 | Cogley Brian | Option exercise | 10K | $10.56 |
| 2026-02-11 | Cogley Brian | Grant | 12K | — |
| 2026-02-11 | Deschamps Philippe | Option exercise | 5.7K | $10.56 |
| 2026-02-11 | Deschamps Philippe | Grant | 3.2K | — |
| 2026-02-11 | Calise Chris | Option exercise | 5.7K | $10.56 |
| 2026-02-11 | Calise Chris | Grant | 3.2K | — |
| 2026-02-11 | Mehalick David | Option exercise | 149K | $7.05 |
| 2026-02-11 | Mehalick David | Grant | 51K | — |
| 2026-02-11 | Yerace Daniel Alexander | Option exercise | 10K | $10.41 |
| 2026-02-11 | Yerace Daniel Alexander | Grant | 20K | — |
| 2026-02-11 | DeSilva Tara | Option exercise | 5.7K | $10.56 |
| 2026-02-11 | DeSilva Tara | Grant | 3.2K | — |
| 2026-02-11 | Cochran Christopher P. | Option exercise | 5.7K | $10.56 |
| 2026-02-11 | Salkind Gene | Grant | 3.2K | — |
| 2026-02-11 | Sheehy Christine Elise | Option exercise | 1.0K | $10.56 |
| 2026-02-11 | Cochran Christopher P. | Grant | 3.2K | — |
| 2026-02-11 | Sheehy Christine Elise | Grant | 12K | — |
| 2026-02-11 | Salkind Gene | Option exercise | 5.7K | $10.56 |
All non-derivative Form 4 activity (SEC), newest first.
Notable events (8-K)
| Date | Items | |
|---|---|---|
| 2026-06-26 | Material agreementReg FDExhibits | filing ↗ |
| 2026-06-04 | Material agreement3.02Reg FDExhibits | filing ↗ |
| 2026-06-01 | Exhibits | filing ↗ |
| 2026-05-22 | Exec/director change | filing ↗ |
| 2026-05-21 | Reg FDExhibits | filing ↗ |
| 2026-05-01 | Material agreement3.02Exec/director changeReg FDOtherExhibits | filing ↗ |
| 2026-04-30 | Acquisition/disposition5.01Exec/director change5.03Exhibits | filing ↗ |
| 2026-04-28 | OtherExhibits | filing ↗ |
Recent filings
| Form | Filed | Period | Accession |
|---|---|---|---|
| 8-K | 2026-06-26 | 2026-06-18 | 0001185185-26-002659 ↗ |
| 8-K | 2026-06-04 | 2026-05-29 | 0001683168-26-004560 ↗ |
| 8-K/A | 2026-06-01 | 2026-04-24 | 0001683168-26-004425 ↗ |
| 8-K | 2026-05-22 | 2026-05-22 | 0001683168-26-004273 ↗ |
| 8-K | 2026-05-21 | 2026-05-19 | 0001683168-26-004194 ↗ |
| 10-Q | 2026-05-15 | 2026-03-31 | 0001683168-26-003948 ↗ |
| 8-K | 2026-05-01 | 2026-04-27 | 0001683168-26-003426 ↗ |
| 8-K | 2026-04-30 | 2026-04-24 | 0001683168-26-003388 ↗ |
| 8-K | 2026-04-28 | 2026-04-27 | 0001683168-26-003247 ↗ |
| 8-K | 2026-04-24 | 2026-04-24 | 0001683168-26-003199 ↗ |
| 8-K | 2026-04-08 | 2026-04-07 | 0001683168-26-002726 ↗ |
| 10-K | 2026-03-19 | 2025-12-31 | 0001683168-26-002026 ↗ |